CSI Market
Sign In | Register

Veracyte Inc (VCYT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access VCYT quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Veracyte Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income66.35
Depreciation & amortization21.42
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability5.21
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Materials and Supplies-2.86
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.02
Share-based Compensation43.60
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total-3.83
Share Based Compensation Non Bonus Related-
Share Based Compensation Bonus Related-
Interest Expense Debt-
Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss-
Convertible Preferred Stock Issuance Costs Incurred But Not Yet Paid-
Fair Value Of Preferred Stock Warrants-
Conversion Of Preferred Stock Warrant Liability Amount Converted-
Conversion Of Stock Amount Converted-
Debt Instrument End Of Term Payment Interest Amount-
Debtinstrument End of Term Payment Interest Amount and Prepayment Penalty-
Tax Benefit from Legal Settlement-
Interest Expense and Prepayment Penalty-
Inventory Reserve Effect On Income Net-
Interest Expense On End of Term Debt Obligation-
Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount-
Debt Instrument End Of Term Payment Interest Amount And Prepayment Penalty-
Noncash Lease Expense2.99
Increase Decrease In Operating Lease Liability-2.48
Increase Decrease In Accrued Liabilities And Deferred Revenue6.32
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.71
Increase (Decrease) in Accounts Payable-1.04
Increase (Decrease) in Accrued Liabilities0.00
Recognition of Deferred Revenue0.00
Increase (Decrease) in Prepaid Expense and Other Assets-2.05
Other Working Capital0.53
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities2.86
Discontinued operations0.00
Net Cash flow from Operating Activities136.31
Investing Activities
Capital Expenditures-9.68
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities153.31
Payments to Acquire Held-to-maturity Securities-150.00
Real Estate Investments0.00
Deconsolidation Gain Loss Amount Investing Activities-2.85
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Proceeds from Divestiture of Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-9.21
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock14.08
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-261.24
Payments Of Stock Issuance Costs Convertible Preferred Stock-
Payments Of Stock Issuance Costs Initial Public Offering-
Payment Of End Of Term Obligation-
Finance Lease Principal Payments-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents240.63
Capital Expenditures Incurred But Not Yet Paid2.31
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-4.22
Effect of exchange rate on cash flow0.72
Discontinued operations0.00
Free Cash Flow126.63
Total Cash Flow246.47
4 historic quarters locked

Sign in to unlock the full Veracyte Inc cash flow history.

Sign In Create Free Account

About Veracyte Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: vcyt-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001384101-26-000010

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License